MedTechIQ_3Helix InSight Engine-Beta
Preview
Open in TheBrain
Triple Helix Discovery Engine
Watch List: Layoffs of 10% or More, Strategic Corporate Review, Delisting, Regulatory, Financial and/or Legal Issues
CureVac N.V. (Nasdaq: CVAC)*
Finance & Acquisitions: CureVac
Parents
CureVac N.V. (Nasdaq: CVAC)*
Children
2017: Eli Lilly is putting up $1.8 billion (€1.5 billion) to work with CureVac on five mRNA cancer vaccines.
2017: Lilly, CureVac pen $1.8 B mRNA cancer vaccine deal
2020: Germany puts €300m in CureVac AG for COVID-19 vaccine
2020: Germany's CureVac Scores $213 Million in IPO
2022: CureVac N.V. 2022 Q3 - Results - Earnings Call Presentation_ seekingalpha.com
2025: BioNTech to acquire CureVac in $1.25 billion all-stock deal_ MSN
Revenue (2018): $12.9 million
Revenue (2019): $17.4 million
Jumps
*Key People: CureVac
Organization & Developments: CureVac